Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupuncture or pills? new study pits needles against meds for anxiety and depression

NCT ID NCT07552246

Symptom relief Sponsor: Duke Kunshan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This study compares acupuncture with standard medication to see which is more effective and affordable for reducing anxiety and mild to moderate depression in adults in China. About 120 people who haven't had mental health treatment in the past 6 months will choose their preferred treatment or be assigned to one. The study also looks at the environmental impact of each treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Chinese nationals 18-65 years old 2. At least one of the screening scores below suggestive of depression/anxiety tendencies: 1. Depressive state: Depression Self-Rating Scale (SDS) raw score ≥43; standard score ≥53 (27) 2. Anxiety state: Anxiety Self-Rating Scale (SAS) raw score ≥40; standard score ≥50 (28) Note: (standard score = raw score X 1.25) Exclusion Criteria: 1. Patients with severe comorbid physical illnesses that prevent them from completing the full course of treatment; 2. Patients with a risk of suicide; 3. Patients with a history of head trauma, loss of consciousness, or severe mental disorders; 4. Patients with drugs or alcohol abuse; 5. Patients who have received physical treatment methods within the past 3 months; 6. Patients who have received antidepressant or antipsychotic medication treatment within the past 3 months; 7. Patients with severe skin lesions or skin diseases.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder mixed anxiety and depressive disorder sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety depression Sleep

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kunshan Mental Health Center and Kunshan Hospital of Traditional Chinese Medicine

    RECRUITING

    Kunshan, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.